Secretin vs Ibutamoren

Head-to-head comparison of Secretin (Human Secretin) and Ibutamoren (Ibutamoren mesylate (MK-677)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertySecretinIbutamoren
CategoryGastrointestinalGrowth Hormone
Full NameHuman SecretinIbutamoren mesylate (MK-677)
Molecular Weight3055.4 DaN/A
Half-Life5-7 minutesabout 24 hours
Amino Acids27N/A
Typical Dose0.2 mcg/kg IV10-25 mg/day
RouteIntravenousOral
Purity≥98%≥98%
Studies Count800180
Research StatusClinicalClinical

Secretin Benefits

  • stimulates-pancreatic-secretion
  • supports-bicarbonate-release
  • aids-duodenal-pH-control
  • helps-digestive-coordination

Ibutamoren Benefits

  • raises GH/IGF-1
  • increases appetite
  • supports lean mass retention
  • oral non-peptide secretagogue

Secretin Dosing

0.2 mcg/kg IV diagnostic dose|research infusion protocols|short bolus administration

Ibutamoren Dosing

10-25 mg orally once daily|take consistently at the same time each day|monitor fasting glucose and edema in longer studies

Secretin Side Effects

  • flushing
  • nausea
  • abdominal-cramping

Ibutamoren Side Effects

  • increased appetite
  • water retention/edema
  • somnolence or lethargy

Research Overview

Secretin

Secretin is a classic GI hormone with extensive physiology literature and established diagnostic use. It remains important for studying pancreatic secretory function, biliary responses, and duodenal feedback.

Ibutamoren

Clinical studies show oral ibutamoren reliably elevates GH and IGF-1 over 24 hours with once-daily dosing. Body composition and appetite effects vary by population, and development has been limited by metabolic side effects.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Secretin stacks with:

pancreatic-enzymesacid-controlmeal-timing

Ibutamoren stacks with:

Resistance trainingHigh-protein diet
pancreatic-secretionbicarbonateduodenal-hormonedigestionghrelin-receptor-agonistgh-secretagogueoral